Merck will support Saudi Arabia effort to build biologics manufacturing operationsnews2021-11-03T14:25:20+00:00November 3rd, 2021|Fierce Pharma|
Amgen’s Lumakras off to a strong start toward analyst’s blockbuster predictions pegged to combo potentialnews2021-11-03T14:16:29+00:00November 3rd, 2021|Fierce Pharma|
By unanimous vote, CDC advisory committee endorses Pfizer COVID-19 vaccine for kids 5-11news2021-11-02T22:16:54+00:00November 2nd, 2021|Fierce Pharma|
Almirall illuminates the emotional side of psoriasis in new awareness campaignnews2021-11-02T21:35:45+00:00November 2nd, 2021|Fierce Pharma|
Novartis teams with advocacy group to bring visibility to atherosclerotic cardiovascular diseasenews2021-11-02T16:57:54+00:00November 2nd, 2021|Fierce Pharma|
Pfizer ups 2021 COVID-19 vaccine sales once again, but it remains coy about future salesnews2021-11-02T16:18:22+00:00November 2nd, 2021|Fierce Pharma|
AbbVie’s Vuity snags FDA approval as first eye drop for presbyopia, with rival Eyenovia closely behindnews2021-11-02T15:42:31+00:00November 2nd, 2021|Fierce Pharma|
AbbVie’s Vuity snags FDA approval as first eye drop for presbyopia, with rival Eyenovia close behindnews2021-11-02T15:42:31+00:00November 2nd, 2021|Fierce Pharma|
Incyte combats insurance hurdles for eczema cream Opzelura, but dermatologists fully on board: execnews2021-11-02T14:08:43+00:00November 2nd, 2021|Fierce Pharma|
Johnson & Johnson, AbbVie, Teva and Endo score industry’s first opioid trial winnews2021-11-02T13:56:35+00:00November 2nd, 2021|Fierce Pharma|
